Pharmacologic (DAPT) or genetic inhibition (myeloid-specific Notch1 KO mice) of Notch in mouse models of alcoholic steatohepatitis or galactosamine/LPS-induced fulminant hepatitis. This evidence concerns the gene NOTCH1 and alcoholic fatty liver disease.